scholarly article | Q13442814 |
P50 | author | Thomas Jespersen | Q42703687 |
Jorgen K. Kanters | Q50884207 | ||
Jacob Tfelt-Hansen | Q54991182 | ||
Helena Carstensen | Q56191531 | ||
Rikke Buhl | Q56191533 | ||
Eva Zander Hesselkilde | Q57443197 | ||
Merle Friederike Fenner | Q58423830 | ||
Mette Flethøj | Q85670819 | ||
Stefan Sattler | Q86947798 | ||
P2093 | author name string | Steen Pehrson | |
Ameli V Loft-Andersen | |||
P2860 | cites work | Recommendations for management of equine athletes with cardiovascular abnormalities | Q26853142 |
Reverse Use Dependence of Antiarrhythmic Class la, Ib, and Ic: Effects of Drugs on the Action Potential Duration? | Q28177913 | ||
Atrial flutter in patients treated for atrial fibrillation with propafenone | Q28336014 | ||
Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation | Q28360262 | ||
Electrocardiographic manifestations: ventricular tachycardia | Q30312174 | ||
Normal electrocardiographic QT interval in race-fit Standardbred horses at rest and its rate dependence during exercise. | Q33162409 | ||
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society | Q34412804 | ||
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation | Q34505579 | ||
Electrical, contractile and structural remodeling during atrial fibrillation | Q34682882 | ||
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination | Q35373187 | ||
Torsade de pointes: the clinical considerations | Q35808897 | ||
Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man | Q36741131 | ||
Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses. | Q36873774 | ||
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode | Q37034727 | ||
Approach to the diagnosis and initial management of the stable adult patient with a wide complex tachycardia | Q37159637 | ||
Alpha-2 Agonists as Pain Therapy in Horses | Q37807712 | ||
Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil | Q43453208 | ||
Management of new onset atrial fibrillation | Q43719248 | ||
Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. | Q45174799 | ||
Use of propafenone for conversion of chronic atrial fibrillation in horses | Q46115043 | ||
Intravenous amiodarone treatment in horses with chronic atrial fibrillation | Q46502632 | ||
Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation. | Q47134767 | ||
Pharmacokinetics and electrophysiological effects of sotalol hydrochloride in horses. | Q48201149 | ||
Effects of an adapted intravenous amiodarone treatment protocol in horses with atrial fibrillation | Q49045361 | ||
Dual-chamber pacemaker implantation via the cephalic vein in healthy equids | Q49052241 | ||
Intracardiac overdrive pacing as a treatment of atrial flutter in a horse | Q49090850 | ||
Atrial and ventricular electrical and contractile remodeling and reverse remodeling owing to short-term pacing-induced atrial fibrillation in horses | Q49152226 | ||
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses. | Q49183821 | ||
Cardiovascular effects of medetomidine, detomidine and xylazine in horses. | Q51372945 | ||
Antiarrhythmic agents: modulated receptor applications. | Q51794509 | ||
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses. | Q54179198 | ||
Changes over time in echocardiographic measurements in young Standardbred racehorses undergoing training and racing and association with racing performance | Q58818025 | ||
Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias | Q68004632 | ||
Factors affecting prognosis and conversion in equine atrial fibrillation | Q68023922 | ||
Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment | Q70412437 | ||
Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation | Q74180025 | ||
Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat | Q77326632 | ||
Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity | Q79286425 | ||
Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation | Q80758288 | ||
Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate | Q85945685 | ||
Treatment of recent-onset atrial fibrillation with quinidine and flecainide in Thoroughbred racehorses: 107 cases (1987-2014) | Q88719110 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atrial fibrillation | Q815819 |
P304 | page(s) | 1708-1717 | |
P577 | publication date | 2018-08-22 | |
P1433 | published in | Journal of Veterinary Internal Medicine | Q15762439 |
P1476 | title | Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses | |
P478 | volume | 32 |
Q99416100 | Catheter-based electrical interventions to study, diagnose and treat arrhythmias in horses: From refractory period to electro-anatomical mapping | cites work | P2860 |